HMGB1 and type 2 diabetes mellitus: In addition, in order to promoting insulin resistance in type 2 diabetic patients, Fetuin-A can also prevent the change of RAGE ligand with (HMGB1), which is responsible the release and absorption of several cytokines, adhesive molecules, and cheomokines.